Regenerative Medical Technology Group Inc. (MSSV)

0,0350 0,0000 (0,00%) Alla chiusura: 11:25AM EDT

Regenerative Medical Technology Group Inc.

433 Plaza Real
Suite 275
Boca Raton, FL 33432
United States
800 956 3935
https://regenmedtechgroup.com

Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. David Eugene Christensen	CEO, CFO, Secretary, Principal Accounting Officer, President & Director	90k	N/D	1966

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Regenerative Medical Technology Group Inc. engages in the stem cell therapy business in the United States and internationally. It provides CELLGENIC FLOW EXOSOMES for hair loss and pain management; CELLGENIC Mesenchymal Stem Cell, which excretes growth factors, cytokines, and proteins for regeneration of tissue; CELLGENIC LYOPHILIZED EXOSOMES that is derived from human umbilical cord mesenchymal stem cells, including potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins and UV radiation reducing agents for skin revitalization; and VITANOVAS that offers in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases. The company also offers GCELL, a closed-system medical device to harness the natural and restorative capabilities of adipose tissue; CELLGENIC SVF, an isolation kit system that has the ingredients and consumables for the extraction of adipose-derived stem cells from fat; CELLGENIC BONE MARROW; CELLGENIC Platelet Rich Plasma for healing and reducing inflammation; CELLGENIC HUMAN PLACENTA; and CELLGENIC ALLOGENEIC PRP. In addition, it is involved in the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic; development of proprietary cell therapy products; and provision of cell collection, cell storage, and training services to physicians. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.

Governance aziendale

L'ISS Governance QualityScore di Regenerative Medical Technology Group Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.